Agilent Technologies (A) vs Revvity (RVTY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Revvity (RVTY) has outperformed Agilent Technologies (A) over the past year, gaining 47.8% versus a gain of 12.6%. Over five years, A leads with a +12.0% price change compared with -20.7% for RVTY. Agilent Technologies is the larger company by market cap ($48.04 billion vs $16.21 billion), about 3.0 times the size.
On valuation, Revvity trades at a lower forward P/E (24.4x vs 25.4x for Agilent Technologies). Agilent Technologies offers the higher dividend yield (0.59% vs 0.19%). Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus 8.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | RVTY |
|---|---|---|
| Share price | $170.38 | $145.22 |
| Market cap | $48.04B | $16.21B |
| 1-day change | -2.83% | -4.20% |
| YTD return | +25.21% | +50.10% |
| 1-year return | +12.65% | +47.78% |
| 5-year return | +12.04% | -20.68% |
| P/E ratio (TTM) | 33.61 | 64.54 |
| Forward P/E | 25.36 | 24.38 |
| EPS (TTM) | $5.07 | $2.25 |
| Dividend yield | 0.59% | 0.19% |
| Annual dividend | $1.01 | $0.28 |
| Revenue (latest FY) | $6.95B | $2.86B |
| Revenue growth (YoY) | +6.73% | +3.67% |
| Net income (latest FY) | $1.30B | $241.20M |
| Gross margin | 52.43% | — |
| Operating margin | 21.29% | 12.49% |
| Net margin | 18.75% | 8.45% |
| 52-week high | $182.99 | $171.74 |
| 52-week low | $108.35 | $81.22 |
| Distance from 52-week high | -6.89% | -15.44% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +7.49% | +18.03% |
| Average volume | 2.32M | 1.91M |
| Shares outstanding | 281.97M | 111.64M |
| Employees | 18,200 | 11,000 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is about 3.0 times larger than Revvity by market value ($48.04B vs $16.21B).
- RVTY has outperformed A by 35.1 percentage points over the past year.
- Revvity trades at a higher earnings multiple (64.5x vs 33.6x trailing P/E).
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus 8.4 cents for Revvity.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Revvity
RVTY stock →Revvity, Inc. provides health sciences solutions, technologies, and services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees
A vs RVTY FAQ
Which is bigger, Agilent Technologies or Revvity?
Agilent Technologies (A) is larger, with a market capitalization of $48.04B compared with $16.21B for Revvity (RVTY).
Which stock has performed better over the past year, A or RVTY?
RVTY returned +47.78% over the past 12 months, compared with +12.65% for A (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, A or RVTY?
A has the lower trailing P/E at 33.6, versus 64.5 for RVTY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Agilent Technologies or Revvity?
Agilent Technologies has the higher yield at 0.59%, compared with 0.19% for Revvity.
Are Agilent Technologies and Revvity in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.